Novavax names VP, government affairs
This article was originally published in Scrip
Novavax, a clinical-stage vaccine company focused on the discovery, development and commercialization of recombinant nanoparticle vaccines and adjuvants, has appointed Brian Rosen vice-president of government affairs and policy. Most recently Mr Rosen was chief policy, advocacy and patient access officer for the Leukemia & Lymphoma Society. He previously developed and ran the government affairs, policy and alliance development functions for MedImmune.